In addition, empagliflozin decreases the accumulation of M1 macrophages, simultaneously induces the anti-inflammatory M2 macrophage phenotype in liver and white AT, and reduces obesity-related chronic inflammation (such as blood TNFα level). The gene discussed is TNF; the disease is obesity disorder.